Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maislos

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
The Journal of Clinical Investigation|March 1, 1986
The source of the circulating aggregate of insulin in type I diabetic patients is therapeutic insulinM Maislos, P M Mead, D H Gaynor, et al.
Diabetes, Obesity & Metabolism|November 13, 2001
Miglitol combined with metformin improves glycaemic control in type 2 diabetesL Van Gaal, M Maislos, G Schernthaner, et al.
European Journal of Clinical Nutrition|March 20, 1998
Gorging and plasma HDL-cholesterol--the Ramadan modelM Maislos, Y Abou-Rabiah, I Zuili, et al.
Archives of Gynecology and Obstetrics|January 1, 1996
Gestational diabetes complicated by severe hypertriglyceridemia and acute pancreatitisJ Bar-David, M Mazor, J R Leiberman, et al.
Archives of Internal Medicine|November 1, 1985
Transitory hypocalcemia complicating measlesR Sobel, S Einhorn, M Maislos, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 1, 1995
Massive splenomegaly responsive to proguanil and with features of hairy cell leukaemiaT Yermiyahu, M Maislos, A Shneider, et al.
The American Journal of Clinical Nutrition|May 1, 1993
Marked increase in plasma high-density-lipoprotein cholesterol after prolonged fasting during RamadanM Maislos, N Khamaysi, A Assali, et al.
Journal of Cardiovascular Risk|May 19, 2000
Efficacy and safety of cerivastatin for type 2 diabetes and hypercholesterolaemia. Hyperlipidaemia in Diabetes Mellitus investigatorsA Rubinstein, F J Maritz, S G Soule, et al.
Diabetes, Obesity & Metabolism|July 7, 2016
Efficacy and safety of switching from sitagliptin to liraglutide in subjects with type 2 diabetes (LIRA-SWITCH): a randomized, double-blind, double-dummy, active-controlled 26-week trialT S Bailey, R Takács, F J Tinahones, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Journal of Clinical Investigation|March 1, 1986
The source of the circulating aggregate of insulin in type I diabetic patients is therapeutic insulinM Maislos, P M Mead, D H Gaynor, et al.
Diabetes, Obesity & Metabolism|November 13, 2001
Miglitol combined with metformin improves glycaemic control in type 2 diabetesL Van Gaal, M Maislos, G Schernthaner, et al.
European Journal of Clinical Nutrition|March 20, 1998
Gorging and plasma HDL-cholesterol--the Ramadan modelM Maislos, Y Abou-Rabiah, I Zuili, et al.
Archives of Gynecology and Obstetrics|January 1, 1996
Gestational diabetes complicated by severe hypertriglyceridemia and acute pancreatitisJ Bar-David, M Mazor, J R Leiberman, et al.
Archives of Internal Medicine|November 1, 1985
Transitory hypocalcemia complicating measlesR Sobel, S Einhorn, M Maislos, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 1, 1995
Massive splenomegaly responsive to proguanil and with features of hairy cell leukaemiaT Yermiyahu, M Maislos, A Shneider, et al.
The American Journal of Clinical Nutrition|May 1, 1993
Marked increase in plasma high-density-lipoprotein cholesterol after prolonged fasting during RamadanM Maislos, N Khamaysi, A Assali, et al.
Journal of Cardiovascular Risk|May 19, 2000
Efficacy and safety of cerivastatin for type 2 diabetes and hypercholesterolaemia. Hyperlipidaemia in Diabetes Mellitus investigatorsA Rubinstein, F J Maritz, S G Soule, et al.
Diabetes, Obesity & Metabolism|July 7, 2016
Efficacy and safety of switching from sitagliptin to liraglutide in subjects with type 2 diabetes (LIRA-SWITCH): a randomized, double-blind, double-dummy, active-controlled 26-week trialT S Bailey, R Takács, F J Tinahones, et al.
Pageof 3